Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/1993
12/15/1993EP0209601B1 Recombinant colony stimulating factor-1
12/15/1993CN1079468A Sulfonamide endothelin antagonists
12/14/1993CA1325205C Substituted flavanoid compounds, their salts, their manufacture and medicines containing these materials
12/12/1993CA2097137A1 Novel estradiol derivative-chlorabucil conjugate, process for preparing the same, and pharmaceutical compositions
12/09/1993WO1993024614A1 Antibodies with specificity for multiple adhesion molecules
12/09/1993WO1993024529A1 Retinal pigmented epithelium derived neurotrophic factor
12/09/1993WO1993024525A1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
12/09/1993WO1993024521A1 Bpc peptides, their preparation and use
12/09/1993WO1993024491A1 Indolocarbazole imides and their use
12/09/1993WO1993024473A1 7-(2-aminoethyl)-benzothiazolones
12/09/1993WO1993024449A1 Peptidyl derivatives and their use as metalloproteinases inhibitors
12/09/1993WO1993024144A1 PREPARATION FOR ACTIVATION OF NATURAL KILLER CELLS (NK-CELLS), SAID PREPARATION CONTAINING INTERFERON-α AND HISTAMINE, SEROTONIN OR SUBSTANCES WITH CORRESPONDING RECEPTOR ACTIVITY
12/09/1993WO1993024142A1 New pharmaceutical uses of krill enzymes
12/09/1993WO1993024127A1 Selective cell inactivation in blood
12/09/1993CA2306952A1 Method for removing dental plaque
12/09/1993CA2136624A1 Peptides of human p53 protein for use in human t cell response inducing compositions, and human p53 protein-specific cytotoxic t-lymphocytes
12/09/1993CA2114622A1 Peptidyl derivatives and their use as metalloproteinases inhibitors
12/08/1993EP0572922A1 Synergistic combinations comprising lipoic acid and vitamines in medicaments
12/08/1993EP0572688A1 Peptides with organo-protective activity, the process for preparing them and their use in therapy
12/08/1993EP0572478A1 A method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases
12/08/1993EP0572454A1 3-desmethylrapamycin or derivatives thereof, processes for their preparation and their use as antifungal agents and immunosuppressants
12/08/1993EP0572451A1 Novel steroid esters
12/08/1993EP0572443A1 Suppression of immune responses with oligomeric forms of antigen of controlled chemistry
12/08/1993EP0267204B1 Immunopotentiation
12/08/1993CN1079166A Use of interleukin-10 to suppress graft-VS.-host disease
12/07/1993US5268454 Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
12/07/1993CA1324953C Bone marrow suppressing agents
12/02/1993DE4217964A1 Indolocarbazol-Imide und deren Verwendung Indolocarbazole imides and the use thereof
12/01/1993EP0572308A2 Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them
12/01/1993EP0572287A2 Use of cyclic double-stranded oligonucleotides containing the binding site for a transcription factor for inhibiting gene expression
12/01/1993EP0571613A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
12/01/1993EP0571502A1 Pmn-derived cr3 modulator and uses thereof
12/01/1993EP0541706A4 Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids
12/01/1993EP0502171A4 Composition for inducing granulocyte production or b cell production in peripheral blood
11/1993
11/30/1993US5266578 Lipoxygenase inhibitors
11/30/1993US5266576 N-myristoyl transferase inhibitors
11/30/1993US5266564 Method for treating certain autoimmune diseases
11/30/1993CA1324792C 3(2h)pyridazinone, process for its preparation and antagonistic agent against srs-a containing it
11/30/1993CA1324762C 3-substituted-2-oxindole-1-carboxamides for suppressing t-cell function
11/30/1993CA1324761C 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
11/26/1993CA2096804A1 Heterocyclic derivatives, method of preparation thereof and pharmaceutical compositions which contain them
11/25/1993WO1993023401A1 8-substituted anthines as phosphodiesterase inhibitors
11/25/1993WO1993023373A1 N-[N'-(5-AMINO-4-HYDROXY-ACYLOYL)-α-AMINOACYLOYL] SUBSTITUTED HETEROCYCLES AND THEIR USE AS ANTIVIRAL AGENTS
11/25/1993WO1993023079A1 Method for nonspecific cellular immune stimulation
11/25/1993WO1993023010A1 Ophthalmic compositions containing a cyclosporin
11/25/1993WO1993019720A3 Compounds
11/25/1993WO1993019178A3 Peptides useful for inducing tolerance
11/25/1993WO1993017684A3 Enantiomeric hydroxylated xanthine compounds
11/25/1993DE4216829A1 Pyridyl derivs. with antithrombotic properties
11/25/1993DE4216364A1 Pyridyl derivs. with antithrombotic properties
11/25/1993CA2136196A1 8-substituted anthines as phosphodiesterase inhibitors
11/25/1993CA2135784A1 Method for nonspecific cellular immune stimulation
11/25/1993CA2133583A1 Antiviral peptides
11/24/1993EP0570829A1 Pharmaceutical composition for intravenous administration containing cyclosporin and method for its preparation
11/24/1993EP0570519A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
11/24/1993EP0570478A1 Mb-40 peptide that enhances the production of interleukin-1 and modulates age-associated immune response
11/24/1993EP0570454A1 Novel steroids
11/23/1993US5264578 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
11/23/1993US5264437 Antiinflammatory agents, immunosuppressants or antiallergens
11/23/1993US5264416 Interleukin-7 receptors
11/18/1993EP0570027A1 T cell receptor-specific for antigen polypeptides and related polynucleotides
11/18/1993EP0569491A1 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
11/18/1993EP0313569B1 Enhancement of the cellular immune response
11/17/1993CN1078470A Optionally substituted pyrido |2,3-d¨ pyrimidine-2,4(1H,3H)-diones and pyrido |2,3-d¨ pyrimidine-2(1H,3H)-ones
11/16/1993US5262425 α-mannosidase inhibitors
11/16/1993US5262423 Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
11/16/1993US5262319 Method for obtaining bone marrow free of tumor cells using transforming growth factor β3
11/16/1993CA1324381C Aryl-substituted naphthyridine and pyridopyrazine derivatives
11/13/1993CA2095006A1 Oxime derivatives
11/13/1993CA2095005A1 Hydroxylamine derivatives
11/11/1993WO1993023405A1 Use of tricyclic pyrimidine derivatives as anti-viral medicaments
11/11/1993WO1993022449A1 Inhibitory factor
11/11/1993WO1993022437A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
11/11/1993WO1993022342A1 Protein l and hybrid proteins thereof
11/11/1993WO1993021959A1 Bystander effect tumoricidal therapy
11/11/1993WO1993021946A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
11/11/1993WO1993021936A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
11/11/1993WO1993021903A1 Use of borate-polyol complexes in ophthalmic compositions
11/11/1993WO1993021771A1 Compositions and methods for regulating il-6 production in vivo
11/11/1993WO1993017712A3 Conjugates formed from heat shock proteins and oligo- or polysaccharides
11/11/1993WO1993001169A3 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
11/11/1993DE4214829A1 Verwendung von tricyclischen Pyrimidin-Derivaten als antivirale Arzneimittel Use of tricyclic pyrimidine derivatives as antiviral drugs
11/11/1993CA2134763A1 Bystander effect tumoricidal therapy
11/11/1993CA2134443A1 Inhibitory factor
11/11/1993CA2134228A1 Compositions and methods for regulating il-6 production in vivo
11/11/1993CA2134218A1 Tricyclic pyrimidine derivatives as antiviral therapeutic agents
11/10/1993EP0569337A1 Heteroatoms-containing tricyclic compounds
11/10/1993EP0569193A1 N-isoxazole-phenylsulfonamide derivatives and their use as endothelin antagonists
11/10/1993EP0569042A1 Medical uses of IL-1 beta
11/10/1993EP0568898A1 Benzothiepine-, benzothiopyrane- and benzothiophenyle derivatives, their preparation and use as medicine
11/10/1993EP0568623A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
11/10/1993EP0440811B1 Composition for percutaneous administration
11/10/1993CN1078153A Methods for using histamine derivatives as immunomodulators and in immunotherapeutics
11/09/1993US5260422 MHC conjugates useful in ameliorating autoimmunity
11/09/1993US5260335 Pharmaceutical preparations for the treatment of inflammatory diseases
11/09/1993US5260300 Useful in treatment of transplant rejection; administering
11/09/1993CA1324155C Dietary supplement utilizing omega-3/medium chain triglyceride mixtures
11/09/1993CA1324143C Quinoline dioic acids and amides
11/09/1993CA1324140C 2-phenyl-3-acylaminomethyl-5,6,7,8-tetrahydroimidazo [1,2-a]pyridine derivatives
11/09/1993CA1324139C 2-phenyl-3-acylaminomethyl-imidazo[1,2-a]pyridine derivatives
1 ... 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 ... 1172